TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Hofseth BioCare ASA
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
126,517
|
84,157
|
57,321 |
| Financial expenses |
8,814
|
9,280
|
8,633 |
| Earnings before taxes |
-70,735
|
-97,058
|
-94,292 |
| Total assets |
258,662
|
290,369
|
310,152 |
| Current assets |
86,859
|
124,157
|
126,985 |
| Current liabilities |
167,003
|
121,669
|
112,537 |
| Equity capital |
27,277
|
104,575
|
104,667 |
| - share capital |
2,620
|
2,791
|
2,668 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
10.5%
|
36.0%
|
33.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-55.9%
|
-115.3%
|
-164.5% |
| Return on assets (ROA) |
-23.9%
|
-30.2%
|
-27.6% |
| Current ratio |
52.0%
|
102.0%
|
112.8% |
| Return on equity (ROE) |
-259.3%
|
-92.8%
|
-90.1% |
| Change turnover |
47,531
|
29,847
|
18,166 |
| Change turnover % |
60%
|
55%
|
46% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.